Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries
- PMID: 26185366
- PMCID: PMC4499337
- DOI: 10.3748/wjg.v21.i26.7933
Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries
Abstract
Esophageal cancer is one of the most unknown and deadliest cancers worldwide, mainly because of its extremely aggressive nature and poor survival rate. Esophageal cancer is the 6(th) leading cause of death from cancer and the 8(th) most common cancer in the world. The 5-year survival is around 15%-25%. There are clear differences between the risk factors of both histological types that affect their incidence and distribution worldwide. There are areas of high incidence of squamous cell carcinoma (some areas in China) that meet the requirements for cost-effectiveness of endoscopy for early diagnosis in the general population of those areas. In Europe and United States the predominant histologic subtype is adenocarcinoma. The role of early diagnosis of adenocarcinoma in Barrett's esophagus remains controversial. The differences in the therapeutic management of early esophageal carcinoma (high-grade dysplasia, T1a, T1b, N0) between different parts of the world may be explained by the number of cancers diagnosed at an early stage. In areas where the incidence is high (China and Japan among others) early diagnoses is more frequent and has led to the development of endoscopic techniques for definitive treatment that achieve very effective results with a minimum number of complications and preserving the functionality of the esophagus.
Keywords: Adenocarcinoma; Barrett’s oesophagus; Early stage; Endoscopic mucosal resection; Endoscopic submucosal disection; Epidemiology; Oesophageal cancer; Screening; Squamous cell carcinoma.
Figures
Similar articles
-
Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.Ann Surg. 2008 Mar;247(3):434-9. doi: 10.1097/SLA.0b013e318163a2ff. Ann Surg. 2008. PMID: 18376186
-
[Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].Zentralbl Chir. 2006 Apr;131(2):97-104. doi: 10.1055/s-2006-921551. Zentralbl Chir. 2006. PMID: 16612774 Review. German.
-
Esophageal Cancer.Gastroenterol Clin North Am. 2016 Sep;45(3):399-412. doi: 10.1016/j.gtc.2016.04.001. Gastroenterol Clin North Am. 2016. PMID: 27546839 Review.
-
Does delayed esophagectomy after endoscopic resection affect outcomes in patients with stage T1 esophageal cancer? A propensity score-based analysis.Surg Endosc. 2018 Mar;32(3):1441-1448. doi: 10.1007/s00464-017-5830-4. Epub 2017 Sep 15. Surg Endosc. 2018. PMID: 28916920
-
Oesophagectomy is a safe option for early adenocarcinoma arising from Barrett's oesophagus.ANZ J Surg. 2016 Nov;86(11):905-909. doi: 10.1111/ans.13023. Epub 2015 Feb 23. ANZ J Surg. 2016. PMID: 25708344
Cited by
-
Inhibition of Insulin-like Growth Factor 1 Receptor/Insulin Receptor Signaling by Small-Molecule Inhibitor BMS-754807 Leads to Improved Survival in Experimental Esophageal Adenocarcinoma.Cancers (Basel). 2024 Sep 17;16(18):3175. doi: 10.3390/cancers16183175. Cancers (Basel). 2024. PMID: 39335147 Free PMC article.
-
MiR-106b promotes migration and invasion through enhancing EMT via downregulation of Smad 7 in Kazakh's esophageal squamous cell carcinoma.Tumour Biol. 2016 Nov;37(11):14595-14604. doi: 10.1007/s13277-016-5338-x. Epub 2016 Sep 12. Tumour Biol. 2016. PMID: 27619676
-
ADAMTS9-AS2 regulates PPP1R12B by adsorbing miR-196b-5p and affects cell cycle-related signaling pathways inhibiting the malignant process of esophageal cancer.Cell Cycle. 2022 Aug;21(16):1710-1725. doi: 10.1080/15384101.2022.2067675. Epub 2022 May 3. Cell Cycle. 2022. PMID: 35503407 Free PMC article.
-
Association of Dietary Nitrate, Nitrite, and N-Nitroso Compounds Intake and Gastrointestinal Cancers: A Systematic Review and Meta-Analysis.Toxics. 2023 Feb 17;11(2):190. doi: 10.3390/toxics11020190. Toxics. 2023. PMID: 36851064 Free PMC article. Review.
-
The Incidence Rate of Esophageal Cancer in Saudi Arabia: An Observational and a Descriptive Epidemiological Analyses.Front Public Health. 2022 Mar 23;10:818691. doi: 10.3389/fpubh.2022.818691. eCollection 2022. Front Public Health. 2022. PMID: 35400030 Free PMC article.
References
-
- Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381:400–412. - PubMed
-
- Wheeler JB, Reed CE. Epidemiology of esophageal cancer. Surg Clin North Am. 2012;92:1077–1087. - PubMed
-
- International agency for research on cancer. Available from: http://globocan.iarc.fr/Default.aspx.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical